|
Description:
|
|
Send us a text Can AI Grade Cancer Better Than Us? The Truth About T-Cell Imaging, Biomarkers & Digital Pathology Disruption
You think Saturday mornings are for coffee? Try diving into bone marrow morphology, organ donor kidney biopsies, and AI-driven metastasis detection at sunrise. That’s how I do it—and you’re invited to join. Welcome to another data-packed episode of DigiPath Digest, where we explore the latest frontier in digital pathology and AI. This time, I reviewed some of the most exciting recent abstracts spanning cancer grading, T-cell quantification, and AI agents in oncology decision-making. These studies aren’t just fascinating—they’re redefining what’s possible in diagnostics, especially in under-resourced areas where digital pathology can create game-changing access and efficiency. |